Drawing based on the description in the official product monograph. No photo yet.
“150 mg tablets: White to off-white, oval shaped, film coated tablets debossed with "I150" on one side and plain on the other side”
I150 pill
Pill with imprint I150 is white, oval and has been identified as Irbesartan 150 mg. It is used for high blood pressure, a weak heart and kidney disease from diabetes. It is supplied by Angita Pharma Inc.
Sold in Canada
Irbesartan 150 mg
- Brand
- AG-Irbesartan
- Imprint
- I150
- Strength
- 150 mg
- Used for
- High blood pressure, a weak heart and kidney disease from diabetes
- Color
- White
- Shape
- Oval
- Form
- Tablet
- Manufacturer
- Angita Pharma Inc
- Drug class
- ARB (blood pressure medicine)
- Sold in
- Canada
- DIN
- 02548224
Source: Health Canada's Drug Product Database and the official product monograph. Last checked .
Report a mistake
What is Irbesartan used for?
Irbesartan is used for high blood pressure, a weak heart and kidney disease from diabetes.
- Medicine type
- ARB (blood pressure medicine)
Official uses from the US prescribing label
Hypertension
Irbesartan tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular (CV) events, primarily strokes and myocardial infarction. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC). Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly. Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal. Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy. Irbesartan tablets may be used alone or in combination with other antihypertensive agents.
Nephropathy in Type 2 Diabetic Patients
Irbesartan tablets are indicated for the treatment of diabetic nephropathy in patients with type 2 diabetes and hypertension, an elevated serum creatinine, and proteinuria (>300 mg/day). In this population, irbesartan tablets reduces the rate of progression of nephropathy as measured by the occurrence of doubling of serum creatinine or end-stage renal disease (need for dialysis or renal transplantation).
From the FDA-approved label on DailyMed (published Sep 28, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows I150.
- It is white, oval.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold in Canada as AG-Irbesartan by Angita Pharma Inc..
In Canada: prescription only.
Ingredients
Active: Irbesartan
Other pills with imprint I 150
Same imprint, different listing. Check the color, size and maker against your pill.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
G521
Metformin Hydrochloride 1000 mg
White, oval, 20 mm
Used for type 2 diabetes
-
G520
Metformin Hydrochloride 500 mg
White, oval, 14 mm
Used for type 2 diabetes
-
CP 296
Ultramicrosize Griseofulvin Tablets 250 mg
White, oval, 14 mm
-
CP 295
Ultramicrosize Griseofulvin Tablets 125 mg
White, oval, 11 mm
-
C 3
Clobazam 20 mg
White, oval, 11 mm
Used for seizures
Schedule IV
-
X1
Sevelamer Carbonate 800 mg
White, oval, 19 mm
Used for hyperphosphatemia
Other Irbesartan pills
- 2772 Irbesartan 150 mg White, oval, 14 mm Used for high blood pressure and a weak heart
- SG 161 Irbesartan 150 mg White, oval, 14 mm Used for high blood pressure and a weak heart
- HH 330 Irbesartan 150 mg White, oval, 12 mm Used for high blood pressure and a weak heart
- ML95 Irbesartan 150 mg White, oval, 14 mm Used for high blood pressure and a weak heart
- HU 150 Irbesartan 150 mg White, oval, 14 mm Used for high blood pressure and a weak heart
- L132 150 Irbesartan 150 mg White, oval, 14 mm Used for high blood pressure and a weak heart
- 159 H Irbesartan 150 mg White, capsule, 11 mm Used for high blood pressure and a weak heart
- LU M12 Irbesartan 150 mg White, oval, 14 mm Used for high blood pressure and a weak heart